Medical News

RSS

New drug derived from magnolia trees proves safe, tolerable in preventing blood clots

A new drug derived from magnolia trees appears to be able to uncouple two important functions of thrombin in blood clot formation and may offer a way to better control the potentially dangerous complications of bleeding and clot formation during procedures to open blocked coronary arteries, say researchers at the Duke Clinical Research Institute (DCRI).

12 Mar 2009

First high-resolution images of the earliest stages of bone formation

Researchers at Eindhoven University of Technology (TU/e) have for the first time made high-resolution images of the earliest stages of bone formation.

12 Mar 2009

New online tool to manage medical device reimbursement across Europe

Factory-CRO announced that it has launched a Web-based tool for medical device companies that wish to market and sell products in Europe.

12 Mar 2009

AMP-activated protein kinase essential contributor to brain growth

An enzyme researchers have studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension and stroke, appears to have yet another major role to play: helping create and maintain the brain.

12 Mar 2009

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

12 Mar 2009

Cracking the spatial memory code

Researchers have shown that they can tell where a person is "standing" within a virtual reality room on the basis of the pattern of activity in the brain alone.

12 Mar 2009

Cells get two chances, not just one, to fix their mistakes

Cells have two chances to fix the same mistake in their protein-making process instead of just one - a so-called proofreading step - that had previously been identified, according to new research.

12 Mar 2009

Body clock regulates energy levels in cells

UC Irvine researchers have discovered that circadian rhythms - our own body clock - regulate energy levels in cells.

12 Mar 2009

Biothera receives approval to launch two lung cancer trials

German regulatory authorities have granted approval to Biothera to conduct two open label, multicenter, randomized Phase II clinical trials studying Imprime PGGÂ® administered in combination with monoclonal antibodies and chemotherapy in patients with non-small cell lung cancer (NSCLC), the company announced today.

12 Mar 2009

New measure for the malignancy of melanoma

Every tumor, starting from a size of a few millimeters, depends on a supply of nutrients and oxygen.

12 Mar 2009

Boosting calcium consumption spurs weight loss

Boosting calcium consumption spurs weight loss, according to a study published in the most recent issue of the British Journal of Nutrition , but only in people whose diets are calcium deficient.

12 Mar 2009

BioCis Pharma starts trial of novel topical drug for dermatology

BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.

12 Mar 2009

Issues cancer survivors face upon the completion of treatment

Survivorship is the new buzz word in cancer care today as advances in the treatment and detection of cancer have resulted in an estimated 12 million cancer survivors in the United States alone.

12 Mar 2009

Giving up smoking before surgery decreases complications

More than a third of patients who took part in an eight-week smoking cessation programme before and after planned surgery were able to give up and most of them were still smoke free after a year, according to research in the March issue of Anaesthesia.

12 Mar 2009

New data on link between cancer and nutrition

European experts in cancer and nutrition are meeting in Zurich, Switzerland late this month to discuss cutting-edge research in one of the most important and fiercely debated topics in cancer prevention: the link between diet and cancer.

12 Mar 2009

Facial muscle relaxant treatments have a negative effect on emotions

One of the most recognizable facial expressions is disgust: the expression displayed by an individual who is exposed to a nauseating image or horrifying story. But what happens when this emotion is not expressed?

12 Mar 2009

Better health and prosperity in Europe via improved clinical research

Improved patient-oriented research in Europe will benefit European citizens and the European medical industry and facilitate the transfer of scientific discoveries from the laboratory bench to the bedside. For Europe and for the rest of the world this effort will be of great importance for the quality of life of individuals and the wellbeing of society as a whole.

12 Mar 2009

Oncolytics Biotech (TSX:ONC, NASDAQ:ONCY) starts U.S. enrolment in trial for non-small cell lung cancer patients

Oncolytics Biotech Inc. has announced that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.

12 Mar 2009

Telehealth for diabetes promotes aging at home, not in the hospital

A large study of ethnically and racially diverse individuals with diabetes has found that home telemonitoring of their health resulted in significantly fewer deaths than in a similar group that was not monitored. Diabetes is the sixth leading cause of death in the United States.

12 Mar 2009

Protein 'magnet' uncovers clue to cancer cell spread

The destruction of a protein 'magnet' could lead to cancer cells breaking away from a tumour and spreading around the body, according to a study in Molecular Cell today (Thursday).

12 Mar 2009